Page last updated: 2024-08-22

galactosamine and Meningitis, Meningococcal, Serogroup A

galactosamine has been researched along with Meningitis, Meningococcal, Serogroup A in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, SR; Bjune, G; Froholm, LO; Lovik, M; Oftung, F1

Other Studies

1 other study(ies) available for galactosamine and Meningitis, Meningococcal, Serogroup A

ArticleYear
A mouse model utilising human transferrin to study protection against Neisseria meningitidis serogroup B induced by outer membrane vesicle vaccination.
    FEMS immunology and medical microbiology, 1999, Volume: 26, Issue:1

    Topics: Animals; Bacteremia; Bacterial Outer Membrane Proteins; Bacterial Vaccines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Galactosamine; Humans; Iron; Meningitis, Meningococcal; Mice; Mice, Congenic; Neisseria meningitidis; Survival Rate; Transferrin

1999